CD4 and neoplasm: In murine models of breast cancer, blocking CSF1/CSF1R signalling inhibited TAM recruitment and delayed tumour regrowth following RT (5 Gy), an effect associated with an increase in CD8+ T cells and a reduction in CD4+ (helper) T cells [36].